NASDAQ:APRI
Delisted

Apricus Biosciences Fund Forecast

$1.03
+0 (+0%)
At Close: May 27, 2022
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Apricus Biosciences Fund and on which exchange is it traded?
The symbol for Apricus Biosciences is APRI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Apricus Biosciences Fund?
Apricus Biosciences holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Apricus Biosciences Fund?
Apricus Biosciences Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Apricus Biosciences Fund.

What's the current price of Apricus Biosciences Fund?
As of the end of day on the 2022-05-27, the price of an Apricus Biosciences (APRI) share was $1.03.

What is the 52-week high and low for Apricus Biosciences Fund?
The 52-week high for Apricus Biosciences Fund is $3.59 and the 52-week low is $0.92.
Click to get the best stock tips daily for free!

About Apricus Biosciences

Apricus Biosciences, Inc., a biopharmaceutical company, focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. The company’s marketing partners for Vitaros include Laboratoires Majorelle, Bracco S.p.A., Hexal AG (Sandoz), Takeda Pharmaceuticals Int... APRI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT